InvestorsHub Logo
Followers 188
Posts 28734
Boards Moderated 1
Alias Born 08/29/2012

Re: namtae post# 395698

Tuesday, 02/13/2024 1:24:05 PM

Tuesday, February 13, 2024 1:24:05 PM

Post# of 400437
It's About To Get Real !!!!!!!!!!!
Glad I could help .
Glad you finally got your toes wet

X 1. Cash Flow Positive Status - 4 years
X 2. Purchase building which houses their cGMP registered facility for research, development, manufacturing and packaging of pharmaceutical products.
X 3. Adderall IR $335 Million Approved and Launched
X 4. Adderall XR $1.56 Billion Approved and Launched
X 5. Double digit quarterly revenues in millions
X 6. In house marketing and distribution: Kirkov
X 7. Prasco/Burel Adderall agreement starting January 1st 2024
X 8. First shipment Adderall XR to PRASCO Dec 2023
X 9. DEA increases manufacturing quotas for Adderall & Vyvance
X 10. Generic Vyvanse - $5.1 BILLION - FDA submission Dec 2023
__11. Generate revenues over $20 million/quarter
__12. Generic OxyContin Approval -;FIRST TO FILE Aug 17, 2023 $720 Million
__13. Prevail over Purdue in Generic OxyContin infringement suit
__14. Purchase or rent additional manufacturing and storage space for new ANDAs
__15. European distribution Dexcel partnership approval by Israeli Health
__16. Full ownership of Adderall IR $ 335 Million
__17. Full ownership of Adderall XR $ 1.56 Billion
__18. Generic Concerta- $1.2 BILLION FDA submission
__19. Vigabatrin - VigPoder approved Pyros $233 Million trade mark challenge
__20. $100 million in yearly revenues
__21. Dopamine Agonist (probably Requip XL or Mirapex ER). $12 Million
__22. Patented Unique ADF (w/o naltrexone)-- NDA
__23. Mikah ANDA (s)
__24. Undisclosed ANDAs/NDAs
__25. Antimetabolite ANDA- Methotrexate -$600 Million
__26. Undisclosed Antimetabolite ANDA- $42 Million
__27. Generic Vyvanse Approval
__28. DollarLand PPS
__29. Uplist to the NASDAQ Exchange
__30. THE Buy Out !
__31. Vegas Baby !!!!!!!
Bullish
Bullish
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ELTP News